high definition radiotherapy - alatro 2017€¦ · 1 desantis ce, cancer treatment and survivorship...

19
1 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY Not available for sale in all markets Dara Chhit AMS Product Marketing November 7, 2017 High Definition Radiotherapy

Upload: others

Post on 05-Aug-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

1 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

Not available for sale in all markets

Dara Chhit AMS Product Marketing November 7, 2017

High Definition Radiotherapy

Page 2: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

2 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

Not available for sale in all markets

Cleverson Lopes Marketing Manager LA November 7, 2017

High Definition Radiotherapy

Page 3: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

3 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

Varian Medical Systems

General Linac Fair Balance Safety Statement

Intended Use Summary

Varian Medical Systems’ linear accelerators are intended to provide stereotactic radiosurgery and precision radiotherapy

for lesions, tumors, and conditions anywhere in the body where radiation treatment is indicated.

Important Safety Information

Radiation treatments may cause side effects that can vary depending on the part of the body being treated. The most

frequent ones are typically temporary and may include, but are not limited to, irritation to the respiratory, digestive, urinary

or reproductive systems, fatigue, nausea, skin irritation, and hair loss. In some patients, they can be severe. Treatment

sessions may vary in complexity and time. Radiation treatment is not appropriate for all cancers.

Medical Advice Disclaimer

Varian as a medical device manufacturer cannot and does not recommend specific treatment approaches. Individual

treatment results may vary.

Page 4: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

4 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

GROWTH IN SRS SRS/SBRT National Forecast, U.S. Adult Market

• Technology innovation

• Increased survival and

need for retreatment

• Cost pressure

* Source: Sg2 Consulting, Skokie, Illinois, U.S.

NOT AVAILABLE FOR SALE IN ALL MARKETS

Page 5: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

5 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

CLINICAL RATIONAL: TREND TOWARDS SRS

• SRS is recommended by NCCN as a primary treatment option for brain

metastases (including n>4).2

• Approximately 20 percent of newly diagnosed cancer patients will develop

brain metastases.1

• An increasing number of patients with brain metastases return for

retreatment.3

• Modern outcomes suggest adverse effects from WBRT on patient cognition

and quality of life. Practice is evolving to SRS alone in patients with up to 4

brain metastases.4

1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version 2.2014. J Natl Compr Canc Netw. 2014. 3 Nieder C et al. Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20

years? Cancer. 2011. 4 Sahgal A et al. Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues. Neuro

Oncol. 2017 NOT AVAILABLE FOR SALE IN ALL MARKETS

Page 6: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

6 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

HYPERARC High-definition radiotherapy for more patients

•Prescribed Immobilization

•Virtual dry run

•Imaging waypoints

Safe*

•Rapid dose fall-off

•SRS NTO

•Optimized collimator angle

Compact Dosimetry

•Automated workflow

•Simplified planning process

•SRS in conventional timeslots

Efficient

*Designed for patient collision prevention NOT AVAILABLE FOR SALE IN ALL MARKETS

Page 7: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

7 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

PRESCRIBED IMMOBILIZATION AND SET-UP

• Immobilization device

modeled in Eclipse™

• Patient Protection Zone

NOT AVAILABLE FOR SALE IN ALL MARKETS

Page 8: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

8 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

CREATE NON-COPLANAR PLAN WITHIN MINUTES*

Defining plan geometry and target doses

• Up to ten prescription doses

• Automatic lower dose objectives

• SRS NTO – Eliminates need to define upper

objectives or to create the shell

structures

.

NOT AVAILABLE FOR SALE IN ALL MARKETS

Page 9: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

9 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

CREATE NON-COPLANAR PLAN WITHIN MINUTES* Auto isocenter placement and trajectory selection

• Isocenter placement based on

center of mass of selected target

volumes

• SRS-specific target quality metrics

calculated automatically

* Varian Summative usability test report. All participants

were able to create HyperArc plan within 8 minutes,

review HyperArc plan within 3 minutes and verify

automated delivery or modify plan within 5 minutes.

NOT AVAILABLE FOR SALE IN ALL MARKETS

Page 10: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

10 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

CREATE NON-COPLANAR PLAN WITHIN MINUTES* Optimized collimator angle for each arc

• Reduction of plan complexity

• Minimal interaction between

targets

• Each target has its own ‘lane’

NOT AVAILABLE FOR SALE IN ALL MARKETS

Page 11: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

11 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

VIRTUAL DRY RUN: COLLISION PRE-CHECK

• Accurate 3D animation of

delivery sequence

• Distance between gantry and

patient protection zone is

displayed and color-coded

• Only collision-free plans

allowed for automated delivery

HYPERARC PLANNING IS 510(K) PENDING. NOT AVAILABLE FOR SALE IN ALL MARKETS

Page 12: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

12 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

AUTOMATED One-click delivery

• CBCT enforced for precise patient

setup

• MV imaging available for

verification

• Optimized treatment delivery order

w/o need to re-enter the room

NOT AVAILABLE FOR SALE IN ALL MARKETS.

Page 13: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

13 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

TREATMENT DELIVERY

Page 14: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

14 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

RAPID DOSE FALL-OFF Increasing dose compactness by distributing more beams around the patient

NOT AVAILABLE FOR SALE IN ALL MARKETS

Coplanar RapidArc® Non-coplanar RapidArc®

Prescription, 20Gy

HyperArc™ HDRT

50% prescription, 10Gy

4Gy

Image courtesy of NHS Greater Glasgow and Clyde

Page 15: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

15 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

RAPID DOSE FALL-OFF: COMPARING PLANS 4Gy

NOT AVAILABLE FOR SALE IN ALL MARKETS

• HyperArc plan (left)

• Typical non-coplanar RapidArc

SRS plan (right)

Page 16: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

16 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

OFFER RADIOSURGERY TO MORE PATIENTS

Safe* • Virtual dry run

• Prescribed Immobilization

• Imaging waypoints

Compact • Rapid dose fall-off

• SRS NTO

• Optimized collimator angle

Efficient • Automated workflow

• Simplified planning process

• SRS in conventional timeslots NOT AVAILABLE FOR SALE IN ALL MARKETS *Designed for patient collision prevention

Page 17: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

17 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

Over the last five years, our radiosurgery plan quality has improved to

equal or exceed our Gamma Knife. Physicians and patients preferred the

frameless and highly efficient delivery on our TrueBeam and Edge systems

and our Gamma Knife was decommissioned June 2017. HyperArc

planning automates much of the radiosurgery treatment planning strategies

that we have implemented at UAB and could enable more clinics to

perform higher quality radiosurgery for more patients.

John Fiveash, M.D., professor and vice chair for academic programs in the UAB Department of Radiation Oncology

Page 18: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

18 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

En los últimos cinco años, la calidad de nuestro plan de radiocirugía ha

mejorado para igualar o superar nuestro Gamma Knife. Los médicos y

pacientes prefirieron la entrega sin marco y altamente eficiente en

nuestros sistemas TrueBeam y Edge y nuestro Gamma Knife se retiró de

servicio en junio de 2017. La planificación de HyperArc automatiza gran

parte de las estrategias de planificación de tratamiento de radiocirugía que

hemos implementado en la UAB y podría permitir que más clínicas hagan

radiocirugía para más pacientes.

John Fiveash, M.D., professor and vice chair for academic programs in the UAB Department of Radiation Oncology

Page 19: High Definition Radiotherapy - ALATRO 2017€¦ · 1 DeSantis CE, Cancer treatment and survivorship statistics, 2014 CA. 2 Nabors LB et al. Central Nervous System Cancers, Version

20 | VARIAN CONFIDENTIAL/PROPRIETARY: DISCLOSED FOR IMMEDIATE RECIPIENT ONLY

THANK YOU